Sulforidazine
From Wikipedia, the free encyclopedia
| Image:Sulforidazine.png | |
| Sulforidazine
| |
| Systematic (IUPAC) name | |
| 10-[2-(1-methyl-2-piperidyl)ethyl]- 2-methylsulfonyl-phenothiazine | |
| Identifiers | |
| CAS number | 14759-06-9 |
| ATC code | ? |
| PubChem | 31765 |
| Chemical data | |
| Formula | C21H26N2O2S2 |
| Mol. weight | 402.575 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Sulforidazine (Imagotan®, Psychoson®, Inofal®) a typical antipsychotic and a metabolite of thioridazine; it and mesoridazine are more potent than the parent compound, whose pharmacological effects are believed by some to be largely due to its metabolism into sulforidazine and mesoridazine.
[edit] References
- PubChem Substance Summary: Sulforidazine National Center for Biotechnology Information.
- ↑ Niedzwiecki DM, Mailman RB, Cubeddu LX. "Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors." Journal of Pharmacology & Experimental Therapeutics. 1984 Mar;228(3):636-9. PMID 6707914

